1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB(活化 B 细胞的核因子 κ 轻链增强子)是一种控制 DNA 转录的蛋白质复合物。NF-κB 存在于几乎所有动物细胞类型中,并参与细胞对压力、细胞因子、自由基、紫外线照射、氧化 LDL 以及细菌或病毒抗原等刺激的反应。NF-κB 在调节对感染的免疫反应中起着关键作用。NF-κB 的错误调节与癌症、炎症和自身免疫性疾病、感染性休克、病毒感染和免疫发育不当有关。NF-κB 还与突触可塑性和记忆过程有关。哺乳动物 NF-κB 家族中有五种蛋白质:NF-κB1、NF-κB2、RelA、RelB、c-Rel。

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-B0190
    Nafamostat

    萘莫司他

    Nafamostat,一种抗凝剂,是一种人工合成的丝氨酸蛋白酶 (serine protease) 抑制剂。Nafamostat 具有抗癌和抗病毒作用,Nafamostat 通过上调肿瘤坏死因子受体 1 (TNFR1) 的表达诱导凋亡 (apoptosis),可用于动脉壁病理性增厚的发生发展。
    Nafamostat
  • HY-N0592
    Demethyleneberberine

    去亚甲基小檗碱

    Inhibitor ≥98.0%
    Demethyleneberberine 是一种天然线粒体靶向抗氧化剂。Demethyleneberberine 通过抑制 NF-κB 通路和调节 Th 细胞的平衡来减轻小鼠结肠炎并抑制炎症反应。Demethyleneberberine 可作为 AMPK 激活剂,用于非酒精性脂肪性肝病 (NAFLD) 的研究。
    Demethyleneberberine
  • HY-N0652R
    2,3,5,4'-Tetrahydroxystilbene 2-O-β-D-glucoside (Standard)

    2,3,5,4-四羟基二苯乙烯葡萄糖苷 (Standard)

    Inhibitor
    2,3,5,4'-Tetrahydroxystilbene 2-O-β-D-glucoside (Standard) 是 2,3,5,4'-Tetrahydroxystilbene 2-O-β-D-glucoside 的分析标准品。本产品用于研究及分析应用。2,3,5,4'-Tetrahydroxystilbene 2-O-β-D-glucoside 是从蓼科植物物种的根里分离出来的,能够抑制5-HETE、HHT 和 thromboxane B2 的形成。2,3,5,4'-Tetrahydroxystilbene 2-O-β-D-glucoside 具有降血压、抗衰老、抗炎、降血脂、心脏保护和神经保护作用。
    2,3,5,4'-Tetrahydroxystilbene 2-O-β-D-glucoside (Standard)
  • HY-16172A
    (S)-DMAPT Inhibitor
    (S)-DMAPT (Dimethylamino Parthenolide) 是Parthenolide (PTL) 的类似物,是具有口服活性的 NF-κB 抑制剂,对原发性急性髓性白血病细胞的LD50 值为1.7 μM。具有潜在的抗肿瘤和抗转移作用。
    (S)-DMAPT
  • HY-W015883S1
    Fumaric acid-13C2 99.9%
    Fumaric acid-13C213C 标记的 Fumaric acid (HY-W015883)。Fumaric acid 是一种不饱和二碳酸,是柠檬酸循环的中间产物,以 ATP 的形式为细胞内提供能量。Fumaric acid 通过抑制依赖 p38 MAPK 的 NF-κB 信号通路发挥抗炎作用。Fumaric acid 可用于妊娠高血压的研究。
    Fumaric acid-<sup>13</sup>C<sub>2</sub>
  • HY-RS11823
    REL Human Pre-designed siRNA Set A Inhibitor
    REL Human Pre-designed siRNA Set A 包括针对 REL (Human) 基因的不同区域设计三对 siRNA,以及阴性对照、FAM 标记阴性对照和阳性对照。
    REL Human Pre-designed siRNA Set A
  • HY-146564
    R-HP210 98.21%
    R-HP210 作用于 NF-κB 介导的栓系反式抑制功能 (IC50=3.80 μM)。R-HP210 抑制 LPS 诱导的多种促炎基因如 IL-1β、IL-6 和 COX-2 的转录。 R-HP210 不会诱导糖皮质激素 (GCs) 的反式激活功能。
    R-HP210
  • HY-N8884
    Coelonin Inhibitor ≥98.0%
    Coelonin 是一种具有抗炎活性的二氢菲。Coelonin 可抑制 LPS 诱导的 PTEN 磷酸化。Coelonin 通过负向调节 PI3K/AKT 通路抑制 NF-κB 激活和 p27Kip1 降解。Coelonin 可抑制 IκBα 的磷酸化和降解,增加 IκBα 蛋白的表达。
    Coelonin
  • HY-P10897
    SjDX5-271 Inhibitor
    SjDX5-271 是一种 3 kDa 小肽。SjDX5-271 抑制 TLR4/MyD88/NF-κB 信号通路。SjDX5-271 诱导细胞极化。SjDX5-271 减轻肝脏炎症。SjDX5-271 保护小鼠免受肝脏缺血-再灌注损伤。
    SjDX5-271
  • HY-P10551
    ApoA-I mimetic peptide 5A Inhibitor
    ApoA-I mimetic peptide 5A 是一种合成的肽类分子,根据天然存在的载脂蛋白A-I (Apo A-I) 的结构和功能设计的。ApoA-I mimetic peptide 5A 能够促进胆固醇从细胞内向外流出,有助于减少细胞内胆固醇的积累。ApoA-I mimetic peptide 5A 还显示出抗炎活性,能够降低血液和组织中的炎症标志物。ApoA-I mimetic peptide 5A 可用于心血管疾病的研究。
    ApoA-I mimetic peptide 5A
  • HY-B0026
    Ceftiofur hydrochloride

    头孢噻呋盐酸盐

    Inhibitor 98.43%
    Ceftiofur hydrochloride 是一种靶向细菌青霉素结合蛋白 (PBPs) 的细胞壁合成抑制剂,在内毒素血症中具有抗炎作用。Ceftiofur hydrochloride 通过抑制细菌细胞壁肽聚糖的合成发挥杀菌作用,导致细菌细胞裂解。Ceftiofur hydrochloride 还抑制 NF-κBMAPKs 的激活,从而减少 TNF-α、IL-1β 和 IL-6 等促炎细胞因子的分泌。
    Ceftiofur hydrochloride
  • HY-N7980
    Rubipodanone A Activator 99.40%
    Rubipodanone A 是一种萘氢醌二聚体,对 A549、BEL-7402、HeLa、HepG2、SGC-7901 和 U251 细胞具有细胞毒性。Rubipodanone A 在 20 μM 和 40 μM 对 NF-κB 也显示出明显的激活作用。
    Rubipodanone A
  • HY-10227S
    Bortezomib-d8

    硼替佐米 d8

    Inhibitor ≥98.0%
    Bortezomib-d8 是 Bortezomib 的氘代物。Bortezomib (PS-341) 是一种可逆性和选择性的蛋白酶体 (proteasome) 抑制剂,通过靶向苏氨酸残基有效抑制 20S 蛋白酶体 (Ki=0.6 nM)。Bortezomib 破坏细胞周期、诱导细胞凋亡以及抑制核因子 NF-κB。Bortezomib 是第一种蛋白酶体抑制剂,具有抗癌活性。
    Bortezomib-d<sub>8</sub>
  • HY-136340
    21-Acetoxypregna-1,4,9(11),16-tetraene-3,20-dione Inhibitor 99.93%
    21-Acetoxypregna-1,4,9(11),16-tetraene-3,20-dione 是 delta 9,11 类固醇类合成的中间体 (intermediate),如 Vamorolone (HY-109017)。delta 9,11 steroids 是糖皮质激素的修饰后的产物,具有抗炎 (anti-inflammatory) 特性。delta 9,11 类固醇类可以用作保护细胞损伤(脂质过氧化)和抑制新生血管的试剂。
    21-Acetoxypregna-1,4,9(11),16-tetraene-3,20-dione
  • HY-106029
    4α-TPA Control ≥99.0%
    4α-TPA 是 TPA 的一种非活性形式,用作 TPA 激活事件的阴性对照。
    4α-TPA
  • HY-N11657
    Sanggenon A

    桑根酮A

    Inhibitor
    Sanggenon A (Sanggenone A) 通过调节 BV2 和 RAW264.7 细胞中的 NF-κB 和 HO-1/Nrf2 信号通路发挥抗炎作用。Sanggenon A 显着抑制脂多糖 (LPS; HY-D1056) 诱导的一氧化氮的产生。
    Sanggenon A
  • HY-135808
    BIZ 114 Inhibitor ≥98.0%
    BIZ 114 (Example 11) 是一种脂肪酸衍生物,可有效抑制 TNF-α 激活的 NF-κΒ 途径。BIZ 114 可用于眼科疾病(例如视网膜退行性疾病和眼部炎症性疾病)的研究。
    BIZ 114
  • HY-128853S
    Taurodeoxycholate-d6 sodium salt

    牛磺脱氧胆酸钠-d6

    Inhibitor 99.4%
    Taurodeoxycholate-d6 sodium salt 是一种胆盐相关的阴离子洗涤剂。Taurodeoxycholate-d6 sodium salt 是在肝脏中将脱氧胆酸与 Taurine (HY-B0351) 偶联形成的。Taurodeoxycholate-d6 sodium salt 可用于分离膜蛋白,包括线粒体内膜蛋白。Taurodeoxycholate-d6 (TDCA) 具有抗炎和神经保护作用。。
    Taurodeoxycholate-d<sub>6</sub> sodium salt
  • HY-124958
    NDMC101 Inhibitor 99.91%
    NDMC101 是一种有效的破骨细胞形成 (osteoclastogenesis) 抑制剂,通过下调 NFATc1 调控基因表达抑制破骨细胞分化。NDMC101 与 DPP4 底物相似,并且通过抑制 DPP4 而抑制早期 T 细胞激活的重要抑制剂。NDMC101 可用于骨疾病的研究,如类风湿关节炎、滑膜炎等。
    NDMC101
  • HY-N3097
    Pellitorine Activator 99.84%
    Pellitorine 是一种具有多种生物活性的天然酰胺类化合物。Pellitorine 可以竞争性地拮抗 Capsaicin (HY-10448) 对 TRPV1 的激活,从而减少疼痛信号传导。Pellitorine 通过上调 BDNF-ERK1/2-CREBNrf2-HO-1 通路改善认知功能障碍。Pellitorine 通过抑制高迁移率组蛋白 B1 (HMGB1) 的释放和 RAGE/TLR4 的表达,发挥抗炎和抗脓毒症的作用。Pelitorine 通过延长凝血时间,抑制凝血因子和凝血酶的活性来发挥其抗血栓作用。Pellitorine 通过上调 GPX4DHODH 等蛋白抑制脂质过氧化、抵抗铁死亡 (ferroptosis)。Pellitorine 可通过抑制 V 型 H⁺-ATP 酶 (V-type H⁺-ATPase) 和 水通道蛋白 4 (AaAQP4) 杀灭埃及伊蚊幼虫。Pellitorine 具有抗癌活性 (如白血病、乳腺癌) 和抑菌活性。
    Pellitorine
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.